Alex Ryan

CMS has made a major tech hire in London, as the firm puts AI at the forefront of its growth strategy.

Linklaters has moved to within touching distance of the £2.5bn revenue mark, posting a 6.8% increase for 2025-26 to take turnover to £2.47bn.

Gateley chief executive officer Rod Waldie ( pictured ) has stepped down for ‘personal, health-related reasons,’ with the announcement coming as the firm reveals its financial results for 2025-26.

CMS has posted a 4.8% increase in global revenues to just under €2.2bn, with revenues for the UK LLP rising at a faster pace, as the firm embarks on its new four-year strategy.

A&O Shearman, Clifford Chance, and Linklaters have each reported their financial results in recent weeks – and the differences in performance underline the diverging strategies among the three firms.

Reports suggest AstraZeneca and Bristol Myers Squibb are considering a potential tie-up, in a deal that could create one of the world’s largest pharmaceutical companies, with a combined value of nearly $400bn.

Ottawa’s AI for All strategy assumes employers will choose the pro-worker path that quarterly market pressure actively punishes, write Joe O’Connor and Alex Ryan

Stephenson Harwood has reported declines in both revenue and profit, with leadership attributing the dip to the cyclical nature of disputes work and emphasising the firm’s longer-term progress.

Paul Hastings has bulked up its London restructuring practice with the hire of two partners from Hogan Lovells Cadwalader and Sidley Austin.

National and regional firms increased their revenue at a faster rate than international or London firms last year, according to preliminary LB100 data – but international firms are surging further ahead on partner profits.